Critical Unit Alert
Correct units: PVRI is expressed in WU·m² (Wood Units × meters squared). A systematic review (Kwan et al., 2019) found over 50% of literature uses incorrect units (like WU/m²), which can lead to clinical misinterpretation and dosing errors.
Hemodynamic Inputs
Standardization to Body Surface Area (BSA) is critical in assessing pulmonary vascular remodeling. PVRI values are less sensitive to body habitus changes than absolute PVR, making it the preferred metric for transplant listing and complex PAH management.
Evidence-Based Hematology Protocol
Reference: Benza RL, et al. Predicting Survival in PAH: REVEAL Risk Score 2.0. Chest. 2019.
Normal thresholds per 2026 ESC/ERS Guidelines for Pulmonary Hypertension.
Verified
Last Review: 2026-07-17
| Category | PVRI (WU·m²) | Clinical Implication |
|---|---|---|
| Normal | < 3 | Normal pulmonary vascular resistance. Low risk for adverse outcomes. |
| Elevated (Mild-Moderate) | 3 – 6 | Pulmonary hypertension. Consider vasodilator testing. |
| Severe Elevation | > 6 | High risk for right heart failure. Relative contraindication for cardiac transplantation (ISHLT). |
| Prohibitive (ASD/VSD closure) | > 3 | AHA/ATS 2015 guidelines advise against defect closure if PVRI >3 WU·m² and PVR index >6 WU·m² post-vasodilator. |
Kwan WC et al. • Clinical Cardiology. 2019;Comprehensive review of PVRI unit confusion across 218 publications. Documents that 54.6% of literature uses incorrect units, with potentially life‑altering consequences.
View SourceGaliè N et al. • European Respiratory Journal. 2015;Defines diagnostic thresholds for PAH including PVRI criteria.
View SourceAbman S et al. • Circulation. 2015;Establishes PVRI > 3 WU·m² as threshold for defining PAH in children and contraindication for ASD/VSD closure.
View SourceMehra MR et al. • Journal of Heart and Lung Transplantation. 2006;Defines PVRI > 6 WU·m² as relative contraindication for cardiac transplantation.
View SourceLast Comprehensive Review: 2026-07-17
Verified
Last Review: 2026-07-17
| Category | PVRI (WU·m²) | Clinical Implication |
|---|---|---|
| Normal | < 3 | Normal pulmonary vascular resistance. Low risk for adverse outcomes. |
| Elevated (Mild-Moderate) | 3 – 6 | Pulmonary hypertension. Consider vasodilator testing. |
| Severe Elevation | > 6 | High risk for right heart failure. Relative contraindication for cardiac transplantation (ISHLT). |
| Prohibitive (ASD/VSD closure) | > 3 | AHA/ATS 2015 guidelines advise against defect closure if PVRI >3 WU·m² and PVR index >6 WU·m² post-vasodilator. |
Kwan WC et al. • Clinical Cardiology. 2019;Comprehensive review of PVRI unit confusion across 218 publications. Documents that 54.6% of literature uses incorrect units, with potentially life‑altering consequences.
View SourceGaliè N et al. • European Respiratory Journal. 2015;Defines diagnostic thresholds for PAH including PVRI criteria.
View SourceAbman S et al. • Circulation. 2015;Establishes PVRI > 3 WU·m² as threshold for defining PAH in children and contraindication for ASD/VSD closure.
View SourceMehra MR et al. • Journal of Heart and Lung Transplantation. 2006;Defines PVRI > 6 WU·m² as relative contraindication for cardiac transplantation.
View SourceLast Comprehensive Review: 2026-07-17
Clinical Context
We think this might be relevant to the clinical guidance for Pulmonary Vascular Resistance Index (PVRI).
Clinical Context
We think this might be relevant to the clinical guidance for Pulmonary Vascular Resistance Index (PVRI).
Clinical Context
We think this might be relevant to the clinical guidance for Pulmonary Vascular Resistance Index (PVRI).
